Increasing evidence links Alzheimer's disease (AD) to various sleep disorders, including
obstructive sleep apnea (OSA). The core AD cerebrospinal fluid (CSF) biomarkers, including …

Introduction Recent studies indicate that Alzheimer's disease-(AD) related biomarkers,
including amyloid β (Aβ40 and Aβ42) and tau proteins (P-tau and T-tau), in blood and …

Alzheimer's disease (AD) is the most common type of dementia and is characterized by the
aggregation of extracellular amyloid-beta and intracellular hyperphosphorylation of tau …

Abstract Study Objectives To determine the effect of self-reported clinical diagnosis of
obstructive sleep apnea (OSA) on longitudinal changes in brain amyloid PET and CSF …

Alzheimer's disease (AD) and obstructive sleep apnea (OSA) are highly prevalent, chronic
conditions with intriguing, yet poorly understood epidemiological overlap. To date, the …

Background: Obstructive sleep apnea (OSA) is associated with cognitive disorders, but little
is known about prevalence of co-occurring OSA and mild cognitive impairment (MCI) as well …

Abstract Study Objectives: Obstructive sleep apnea (OSA) is a common sleep disorder. The,
literature lacks studies examining sleep, cognition, and Alzheimer's Disease (AD) …

Objectives Obstructive sleep apnea (OSA) may increase the risk of Alzheimer's disease
(AD). However, potential associations among sleep-disordered breathing, hypoxia, and OSA …

Previous studies have demonstrated that sleep-breathing disorders, and especially
obstructive sleep apnea (OSA), can be observed in patients with a higher risk of progression …

Introduction Obstructive sleep apnea (OSA) is associated with Alzheimer's disease (AD)
biomarkers in cognitively normal (CN) and mild cognitive impaired (MCI) participants …